Insulet
Manufacturing · Massachusetts, United States · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
100 Nagog Park, Acton, Massachusetts, Un...Phone Number
(866) 941-0155Website
www.insulet.comRevenue
$2.9 BillionStock Symbol
PODDIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
9
1
2
2
2
1
About Insulet
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.Explore more
Insulet Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Insulet your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Insulet had a recent Job posting/layoffs
Insulet, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Insulet
Earning: See what the market has to say on Insulet recently announced quarterly report
Funding: Get notified immidiatlly once Insulet has new funding data
Product Launch: Get notified when Insulet launches new products
Website visits: Recent activity has been detected on your website
Check out if Insulet is spiking on competitors!
Check if Insulet has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Insulet
Find 2 more new buyers
Compare Similar Companies to Insulet
Compare insights from companies similar to Insulet, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Insulet is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Insulet is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Insulet.
Insulet financials insights
Gather financial insights about Insulet, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Stock Offering
$115.5M
2009
Debt
$60M
Insulet Tech Stack
A closer look at the technologies used by Insulet
Most Recent Scoops
Person-Based
Machine Learning, Artificial Intelligence
Open Position
Open Position
Open Position
Open Position
Insulet News & Media
Important Notice to Long-Term Shareholders of First Solar, Inc. (NSADAQ: FSLR); Insulet Corporation (NASDAQ: PODD); Photronics, Inc. (NASDAQ: PLAB); and Via Transportation, Inc. (NYSE: VIA): Grabar Law Office is Investigating Claims on Your Behalf
First Solar, Inc. (NSADAQ: FSLR); Insulet Corporation (NASDAQ: PODD); Photronics, Inc. (NASDAQ: PLAB); and Via Transportation, Inc. (NYSE: VIA) ShareholderInsulet (NASDAQ:PODD) Safety Issues Trigger Securities Fraud Class Action – Investors Notified to Contact BFA Law about the Lawsuit
Insulet (NASDAQ:PODD) Safety Issues Trigger Securities Fraud Class Action – Investors Notified to Contact BFA Law about the LawsuitSueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD
Notice to Pension Funds, Asset Managers, and Fiduciaries Holding PODD: Institutional Portfolios Face Significant Exposure Following Two Omnipod Medical Device Corrections and Over $90 Per Share Decline from Pre-Disclosure Levels NEW YORK, July 9, 2026 /PRNewswire/ -- Institutional...Deadline Alert: Insulet Corporation (PODD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, July 09, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 31, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”).
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Insulet
Sign Up For FreeTo access detailed company insights
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple,... Read More
